MSF calls for insulin manufacturers to provide $1 injection pens globally, emphasizing current high prices and limited access ...

Doctors Without Borders (MSF) is calling on Eli Lilly, Novo Nordisk and Sanofi to immediately reduce the price of insulin ...

Novo Nordisk has made its smart insulin pens available in the UK, giving people treated within the NHS for diabetes access to devices that can monitor and record dosing information for the first time.

EU antitrust regulators have asked pharma rivals and customers for feedback in four business areas in light of Novo Holdings' ...

The international medical charity Doctors Without Borders has called on leading pharmaceutical corporations and "all insulin ...

Novo Nordisk has signed off on a $285 million biobucks deal with fellow Denmark-based company Ascendis Pharma to help the Wegovy manufacturer develop a once-monthly GLP-1 receptor agonist.

With the rise in the popularity of weight loss drugs like ‘Wegovy’ and ‘Ozempic,’ we’re learning a counterfeit market has ...

80% of people with diabetes live in low- and middle-income countries, where access to insulin pens is extremely limited due primarily to high prices Eli Lilly, Novo Nordisk, and Sanofi control and ...

Novo Nordisk, the pharma giant behind Ozempic and Wegovy, has surprising love story origins. The founders, a married couple, ...

Novo Nordisk landed in hot water with the FDA following an inspection at one of the drugmaker’s key semaglutide and insulin manufacturing plants this past spring. | The FDA issued a ...

Even after dramatic price cuts, a month's supply of injector pens may still cost more than $150 ... for their employer and ...

Novo Nordisk remains a sell due to increased competition ... with a 54.8% market share in GLP-1 and a 43.9% market share in insulin (33.8% total diabetes market share). As this share has grown ...